J&J | JNJ - Les Charges D'Exploitation

Prix De L'Action
227.79
Variation Quotidienne
2.45 1.09%
Mensuellement
-6.06%
Annuel
46.10%
Q2 Prévisions
222.63




Les Charges D'Exploitation Changement Date
AbbVie USD 10.81B 13.45B 2025-12
Abbott USD 9.31B 104M 2026-03
Amgen USD 5.9B 773M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Bayer EUR 10.33B 126M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Biogen USD 1.88B 81.4M 2025-09
Boston Scientific USD 4.15B 107M 2026-03
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
CONMED USD 336.58M 10.53M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Eli Lilly USD 10.31B 1.09B 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.28B 16M 2025-12
Merck USD 10.16B 558M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Novartis USD 9.8B 61M 2025-12
Pfizer USD 12.91B 79.89B 2025-12
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 9.31B 1.2B 2026-03
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12
Zoetis USD 1.55B 3.85B 2025-12